Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Visual acuity and depressive symptoms after first eye cataract surgery in elderly patients

Poster Details

First Author: S. Jovanovic SERBIA

Co Author(s):    F. Radotic   N. Djonovic   Z. Jovanovic              

Abstract Details

Purpose:

The aim of this research is to determine the potential impact of visual acuity on the occurrence of depressive symptoms in elderly patients before and after first eye cataract surgery.

Setting:

The study lasted from May 2014 until May 2015 in the Eye Clinics, Clinical Centre 'Kragujevac', the Republic of Serbia

Methods:

Sample: The total number of patients was 435, 234 men and 201 women. Procedure: The patients who participated in the study were required to complete the GDS-15 scale. The GDS-15 scale was filled out twice, two weeks prior to surgery and four weeks after surgery

Results:

Statistical analysis showed that a significant difference exists in the level of visual acuity before and after surgery (p<0.001). The results of the GDS-15 scale before and after cataract surgery indicated a significant difference (p<0.003). Further group testing of depressive symptoms before and after surgery has shown: without symptoms (p<0.003), mild symptoms (p<0.002), moderate symptoms (p<0.001) and severe symptoms (p<0.004). The visual acuity in the non-operated eye has an important role in depressive symptoms before (p<0.002) and after (p<0.001) cataract surgery

Conclusions:

The study found that a statistically significant difference exists between the loss of visual acuity and the occurrence of depressive symptoms before and after first eye cataract surgery. Visual acuity is a very important factor in reducing depressive symptoms in older patients.

Financial Disclosure:

NONE

Back to Poster listing